BiotechTube
Home/Pipeline/Undisclosed Cardiovascular Program(s)

Undisclosed Cardiovascular Program(s)

Cardiovascular Disease

Clinical-stage (phase unspecified)Active

Key Facts

Indication
Cardiovascular Disease
Phase
Clinical-stage (phase unspecified)
Status
Active
Company
Salubris Biotherapeutics

About Salubris Biotherapeutics

Salubris Biotherapeutics is a private, clinical-stage biotech founded in 2015 and headquartered in Gaithersburg, Maryland. The company is developing novel antibody-based therapeutics targeting the two leading global causes of death: cardiovascular disease and cancer. Led by a seasoned team of industry veterans, SalubrisBio leverages its expertise in complex biologics to advance its pipeline through clinical development. The company is currently pre-revenue and focused on progressing its research programs.

View full company profile

Therapeutic Areas

Cardiovascular DiseaseOncology

Other Cardiovascular Disease Drugs

DrugCompanyPhase
Manocept DiagnosticNavidea BiopharmaceuticalsResearch
Undisclosed Therapeutic Program(s)HeartcoR SolutionsPre-clinical
Ramatroban (KAR101)KARE BiosciencesPreclinical
Undisclosed Cardiovascular Device ProgramTransluminal TechnologiesPre-clinical
iPSC-CM Cell TherapyKhloris BiosciencesResearch
Clinical Trial IntegrationAktiiaVarious
Cardiovascular Disease StudyArizona Research CenterNot Specified
Cardiovascular Clinical TrialsPanThera BioNot Specified
UndisclosedZecardio TherapeuticsDiscovery/Pre-clinical
HDL/LDL RegulationAlpha-1 BiologicsPre-clinical
Cardiovascular ProgramHelixomerResearch
Undisclosed Cardiovascular PrograminQB8 Medical TechnologiesPre-clinical